ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• You Don't Have To Digitize Everything, You Just Have To Start

  Feeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.

• Position Your DHT Innovation For Success

  Explore three factors that significantly influence the success of clinical trials incorporating digital health technology.

• AI Needs A Home: Inside The Workflows That Drive Trials

  Move beyond fragmented digital tools. Learn how a governed execution layer transforms AI into a collaborator, streamlining trial decisions and creating a traceable record of human-AI insight.

• Simplifying ePRO Data Collection

  The Bring Your Own Device (BYOD) model, supported by Trialkit, is an innovative approach in clinical trials that allows participants to use personal smartphones or tablets for data collection.

• Experts Discuss AI's Future In Pharma

  At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.

• eCOA Best Practices For Crohn's And UC Trials

  Around 200 trials annually use tools like the Crohn’s Disease Activity Index (CDAI) and Modified Mayo Score (mMS) to measure clinical remission. Implementing these in eCOA systems requires careful planning.

• A Blueprint For Modern Obesity Research

  The landscape of obesity and GLP-1 research has reached a saturation point. To successfully scale to the 5,000-patient registries now required for long-term evidence, a shift in operational architecture is essential.

• Benefits Of Delegating Your Oncology Trials Patient Screening Process

  Explore the integration of Electronic Health Records (EHR) into oncology clinical trials, highlighting both challenges and potential advancements.

• Connecting The Right Patients To The Right Trial

  Direct outreach to potential participants and communication with their healthcare providers is key to boosting trial awareness and participation, thereby achieving recruitment targets.

• Finding The Optimal IRT/RTSM Design For Your Clinical Trial

  Determine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.